Genevieve Claire Combes - 09 Dec 2025 Form 4 Insider Report for HARTE HANKS INC (HHS)

Reporting relationship: Director
Issuer ticker: HHS
Reported as of: 09 Dec 2025
Net transaction value: +$89,991
SEC form: 4
Accepted by SEC: 15 Dec 2025, 16:03:12 UTC
Prior SEC filing: 31 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Robert Wyman, Attorney-in-fact for Genevieve Combes

Key filing fact

Genevieve Claire Combes filed Form 4 for HARTE HANKS INC (HHS) on 15 Dec 2025.

Key facts

This page summarizes Genevieve Claire Combes's Form 4 filing for HARTE HANKS INC (HHS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Dec 2025, 16:03.

Change

Previous filing in this sequence was filed on 31 May 2024.
Current net transaction value: +$89,991.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001383909 Primary reporting owner

Combes Genevieve Claire

Relationship: Director
Address: 1 EXECUTIVE DRIVE, SUITE 303, CHELMSFORD
Signature: /s/ Robert Wyman, Attorney-in-fact for Genevieve Combes
Signature date: 15 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HHS transaction

Common Stock

Award

Transaction value: $89,991
Shares: +27,861
Change %
Price: $3.23
Shares after: 27,861
Date: 09 Dec 2025
Ownership: RSU shares held by Harte Hanks, granted to the participant but not yet vested
Footnotes: F1

HHS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,048
Date: 09 Dec 2025
Ownership: RSU shares held by Harte Hanks, granted to the participant but not yet vested
Footnotes: F2

HHS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 26,283
Date: 09 Dec 2025
Ownership: Direct

HHS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 16,216
Date: 09 Dec 2025
Ownership: RSU shares held by Harte Hanks, granted to the participant but not yet vested
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Participant was granted 27,861 RSU shares on 12/09/2025 that will vest 100% on the first anniversary of the grant date.

Footnote F2

Participant was granted 12,048 RSU shares on 5/23/2024 that vested 100% on 5/23/.2025, but the participant chose to defer receipt of the vested shares until a later date.

Footnote F3

Participant was granted 16,216 RSU shares on 8/17/2023 that vested 100% on 8/17/2024, but the participant chose to defer receipt of the vested shares until a later date.